Prevalence of Sarcopenia and Its Geriatric Features

Completed

• Conditions: Sarcopenia
• Interventions: Other: Sarcopenia detection

• Registration Number: NCT02664376
• Lead Sponsor: Brugmann University Hospital

Brief Summary

The goal of this study is to determine the prevalence of sarcopenia in a geriatric hospital ward.

Sarcopenia is defined by a loss of muscle mass, loss of muscle strength and loss of muscle quality. It is a geriatric syndrome that, to this date, is not systematically tracked in clinical practice.

In order to detect sarcopenia, the investigators will use the operational definition proposed by the European Working Group (EWGSOP) involving the measure of three parameters, namely the speed of walking, the muscle strength and the measurement of the muscular mass.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01-01
• Study First Submitted: 2016-01-19
• Study First Submitted QC: 2016-01-22
• Study First Posted: 2016-01-27
• Status Verified: 2018-01
• Primary Completion: 2018-01-18
• Study Completion: 2018-01-18
• Last Update Submitted: 2018-01-25
• Last Update Posted: 2018-01-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 834

Inclusion Criteria

• To be admitted in the unit 83 of the Geriatric Departement of the CHU Brugmann hospital, from 10/01/2016 till 30/03/2017.

Exclusion Criteria

• Patients unable to consent or without representatives
• Patients unable to perform the hand- grip test, the walk test or measurement of the body components by DEXA
• Patients in severe pain
• Bedridden patients
• Patients for which a clear therapeutic abstention has been established
• Language barriere that cannot be overcome
• Patients unable to walk without the help of a third person

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Geriatric ward population	Sarcopenia detection	Every patient aged over 65 admitted in the unit 83 of the Geriatry Department, CHU Brugmann Hospital, undergoes a global geriatric evaluation at the end of its hospitalisation stay, including sarcopenia detection.

Primary Outcome Measures

Name	Time	Method
Prevalence of sarcopenia	From 10/01/2016 till 30/03/2017 (up to 15 months)	Sarcopenia detection will be performed at the end of each hospitalization stay in unit 83 of the CHU Brugmann Hospital (Geriatry Department)

Secondary Outcome Measures

Name	Time	Method
Percentage of hospitalized patients unable to perform the sarcopenia detection test	From 10/01/2016 till 30/03/2017 (up to 15 months)	Systematic retrospective review of patients hospitalised in the geriatric ward of the CHU Brugmann hospital during the length of the study, in order to determine the percentage of patients that could not, because of one of more exclusion criteria, perform the sarcopenia detection test.

Trial Locations

Locations (1)

CHU Brugmann; 🇧🇪 Brussels, Belgium